Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2013

01-08-2013 | Commentary

A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment

Authors: Pablo Moura Santos, Lúcia Noblat, Álvaro A. Cruz

Published in: International Journal of Clinical Pharmacy | Issue 4/2013

Login to get access

Abstract

Asthma is a chronic inflammatory disorder of the airways that is characterized by recurrent symptoms associated with airflow limitation and by bronchial hyper-responsiveness. Free asthma treatment has been guaranteed in Brazil since 2003, notably after the Brazilian government decided to support drugs for the most serious forms of the disease. The asthma treatment access policy in Brazil offers a new opportunity for pharmacists to work closely with patients, and for caregivers and health care teams to promote educational activities and patient counselling about asthma. Pharmacists have an important role in the management of drug therapy within the health care team. Pharmacists should be prepared to engage with the latest concept of health care delivery proposed for Brazilian Unified Health System. These are centred on forming health care networks and strengthening multidisciplinary teams to integrate all professionals who are in charge of patient care.
Literature
1.
go back to reference World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva: World Health Organization; 2007.
2.
go back to reference Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.PubMedCrossRef Franco R, Santos AC, do Nascimento HF, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.PubMedCrossRef
3.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed
4.
go back to reference Ministério da Saúde (Brasil). Portaria no. 1.146 de 1 de junho de 2012. Altera e acresce dispositivos à portaria n 971/GM/MS, de 17 de maio de 2012, para ampliar a cobertura da gratuidade no âmbito do Programa Farmácia Popular do Brasil. Diário Oficial da União 2012; 1:107. [Brazilian Ministry of Health. Decree no. 1146 of 1 June 2012. Amends and adds provisions to the Decree no. 971/GM/MS of May 17, 2012, to expand the coverage of gratuity under the Popular Pharmacy Program in Brazil. Official Gazette 2012; 1:107]. Ministério da Saúde (Brasil). Portaria no. 1.146 de 1 de junho de 2012. Altera e acresce dispositivos à portaria n 971/GM/MS, de 17 de maio de 2012, para ampliar a cobertura da gratuidade no âmbito do Programa Farmácia Popular do Brasil. Diário Oficial da União 2012; 1:107. [Brazilian Ministry of Health. Decree no. 1146 of 1 June 2012. Amends and adds provisions to the Decree no. 971/GM/MS of May 17, 2012, to expand the coverage of gratuity under the Popular Pharmacy Program in Brazil. Official Gazette 2012; 1:107].
6.
go back to reference Ministério da Saúde (Brasil). Portaria no. 1.318 de 23 de julho de 2002. Diário Oficial da União. 2002;1:68. [Ministry of Health. Decree no. 1318 of 23 July 2002. Official Gazette 2002; 1:68]. Ministério da Saúde (Brasil). Portaria no. 1.318 de 23 de julho de 2002. Diário Oficial da União. 2002;1:68. [Ministry of Health. Decree no. 1318 of 23 July 2002. Official Gazette 2002; 1:68].
7.
go back to reference Ministério da Saúde (Brasil). Portaria no. 2.577 de 27 de outubro de 2006. Diário Oficial da União. 2006;1:44. [Ministry of Health. Decree no. 2577, 27 October 2006. Official Gazette 2006, 1:44]. Ministério da Saúde (Brasil). Portaria no. 2.577 de 27 de outubro de 2006. Diário Oficial da União. 2006;1:44. [Ministry of Health. Decree no. 2577, 27 October 2006. Official Gazette 2006, 1:44].
8.
go back to reference Ministério da Saúde (Brasil). Portaria no. 2.084 de 26 de outubro de 2005. Diário Oficial da União. 2006;1:44. [Ministry of Health Decree no. 2084 of 26 October 2005. Official Gazette 2006, 1:44]. Ministério da Saúde (Brasil). Portaria no. 2.084 de 26 de outubro de 2005. Diário Oficial da União. 2006;1:44. [Ministry of Health Decree no. 2084 of 26 October 2005. Official Gazette 2006, 1:44].
9.
go back to reference Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o manejo da asma. J Bras Pneumol. 2012; 38 Suppl 1: S1-S46. [Guidelines of the Brazilian Thoracic Association for the Treatment of Asthma]. Diretrizes da Sociedade Brasileira de Pneumologia e Tisiologia para o manejo da asma. J Bras Pneumol. 2012; 38 Suppl 1: S1-S46. [Guidelines of the Brazilian Thoracic Association for the Treatment of Asthma].
10.
go back to reference Cerci Neto A, Ferreira Filho OF, Bueno T, et al. Reduction in the number of asthma-related hospital admissions after the implementation of a multidisciplinary asthma control program in the city of Londrina, Brazil. J Bras Pneumol. 2008;34(9):639–45.PubMedCrossRef Cerci Neto A, Ferreira Filho OF, Bueno T, et al. Reduction in the number of asthma-related hospital admissions after the implementation of a multidisciplinary asthma control program in the city of Londrina, Brazil. J Bras Pneumol. 2008;34(9):639–45.PubMedCrossRef
11.
go back to reference Franco R, Nascimento HF, Cruz AA, et al. The economic impact of severe asthma to low-income families. Allergy. 2009;64:478–83.PubMedCrossRef Franco R, Nascimento HF, Cruz AA, et al. The economic impact of severe asthma to low-income families. Allergy. 2009;64:478–83.PubMedCrossRef
12.
go back to reference Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 1, Art. No. CD000336. doi: 10.1002/14651858.CD000336.pub4. Nkansah N, Mostovetsky O, Yu C, et al. Effect of outpatient pharmacists’ non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 1, Art. No. CD000336. doi: 10.​1002/​14651858.​CD000336.​pub4.
13.
go back to reference Santos DB, Cruz AA, Simões SM, et al. Pattern of asthma medication use among children from a large urban center in Brazil. Eur J Clin Pharmacol. 2012;68(1):73–82.PubMedCrossRef Santos DB, Cruz AA, Simões SM, et al. Pattern of asthma medication use among children from a large urban center in Brazil. Eur J Clin Pharmacol. 2012;68(1):73–82.PubMedCrossRef
14.
go back to reference Santos DO, Martins MC, Cipriano SL, et al. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. J Bras Pneumol. 2010;36(1):14–22.CrossRef Santos DO, Martins MC, Cipriano SL, et al. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. J Bras Pneumol. 2010;36(1):14–22.CrossRef
15.
go back to reference Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician’s Guide. 2nd ed. The McGraw-Hill, c2004. ISBN 0-07-136259-2. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Clinician’s Guide. 2nd ed. The McGraw-Hill, c2004. ISBN 0-07-136259-2.
16.
go back to reference Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902.PubMedCrossRef Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902.PubMedCrossRef
Metadata
Title
A policy of free access to asthma medicines in Brazil: an opportunity for pharmacists to optimize asthma treatment
Authors
Pablo Moura Santos
Lúcia Noblat
Álvaro A. Cruz
Publication date
01-08-2013
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2013
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9807-7

Other articles of this Issue 4/2013

International Journal of Clinical Pharmacy 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.